Donald Wuchterl
Director/Miembro de la Junta en ABEONA THERAPEUTICS INC. .
Fortuna: 329 275 $ al 31/05/2024
Cargos activos de Donald Wuchterl
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. | Director/Miembro de la Junta | 19/04/2021 | - |
| Independent Dir/Board Member | 19/04/2021 | - |
Historial de carrera de Donald Wuchterl
Antiguos cargos conocidos de Donald Wuchterl.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| T-Knife Therapeutics, Inc. | Corporate Officer/Principal | 01/04/2021 | 01/08/2022 |
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2016 | 01/01/2021 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Director de Operaciones | 01/07/2012 | 01/01/2016 |
Formación de Donald Wuchterl.
| Fitchburg State University | Masters Business Admin |
| Colorado Technical University, Inc. | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
| T-Knife Therapeutics, Inc. |
- Bolsa de valores
- Insiders
- Donald Wuchterl
- Experiencia
